Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.94 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ACLY | P53396 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL8973204 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL316826 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL5515900 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL10751372 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL47868 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL4009914 | 1.00 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL25190736 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL16345363 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL1135947 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL372319 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116060013-A | Method for preparing carbon-coated bimetallic hydrogenation catalyst through hydrothermal carbonization | 中国科学院兰州化学物理研究所 | 2023-05-05 | — | — | CN | claimed |
| US-20200354847-A1 | COMPOSITIONALLY MODULATED ZINC-IRON MULTILAYERED COATINGS | THE BOEING COMPANY | 2020-11-12 | — | — | US | claimed |
| CN-104911128-B | A kind of thermophilic anaerobic bacillus and its application in production lactic acid | 华南理工大学 | 2019-01-29 | — | — | CN | claimed |
| US-20180355497-A1 | COMPOSITIONALLY MODULATED ZINC-IRON MULTILAYERED COATINGS | THE BOEING COMPANY | 2018-12-13 | — | — | US | claimed |
| EP-3412799-A1 | COMPOSITIONALLY MODULATED ZINC-IRON MULTILAYERED COATINGS | The Boeing Company (US) | 2018-12-12 | — | — | EP | claimed |
| US-10117971-B2 | Antimicrobial compositions and methods for locking catheters | BECTON, DICKINSON AND COMPANY (US) | 2018-11-06 | — | — | US | claimed |
| US-20180126044-A1 | Antimicrobial Compositions and Methods for Locking Catheters | BECTON, DICKINSON AND COMPANY | 2018-05-10 | — | — | US | claimed |
| US-9872941-B2 | Antimicrobial compositions and methods for locking catheters | BECTON, DICKINSON AND COMPANY (US) | 2018-01-23 | — | — | US | claimed |
| EP-3263145-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | Becton, Dickinson and Company (US) | 2018-01-03 | — | — | EP | claimed |
| EP-2391632-B1 | BACTERIOSTATIC CATHETER LOCK CONTAINING GLYCEROL | TELEFLEX MEDICAL INC (US) | 2017-11-15 | — | — | EP | claimed |
| EP-2012599-B1 | CALCIUM ENRICHMENT COMPOSITIONS METHOD OF PRODUCTION THEREOF AND USE | GADOT BIOCHEMICAL IND LTD (IL) | 2010-04-28 | — | — | EP | claimed |
| WO-2009147667-A1 | PRODUCTION OF POTASSIUM MAGNESIUM CITRATE AND ITS APPLICATIONS | GADOT BIOCHEMICAL INDUSTRIES LTD. (IL) | 2009-12-10 | — | — | WO | claimed |
| JP-2009528360-A | — | — | 2009-08-06 | — | — | JP | claimed |
| US-20090142451-A1 | Calcium Enrichment Compositions Method of Production Thereof and Use | GADOT BIOCHEMICAL INDUSTRIES LTD (IL) | 2009-06-04 | — | — | US | claimed |
| EP-1998825-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | Becton, Dickinson and Company, Wagner, Jaconda (US) | 2008-12-10 | — | — | EP | claimed |
| WO-2007100776-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON, DICKINSON AND COMPANY (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070202177-A1 | Antimicrobial Compositions and Methods for Locking Catheters | BECTON, DICKINSON AND COMPANY (US) | 2007-08-30 | — | — | US | claimed |
| EP-1245247-A1 | Biocidal locks | Biolink Corporation (US) | 2002-10-02 | — | — | EP | claimed |
| US-6350251-B1 | Biocidal locks | BIOLINK CORPORATION | 2002-02-26 | — | — | US | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |